DK0797993T3 - Præparater omfattende L-carnitin eller derivater deraf og antioxidanter - Google Patents
Præparater omfattende L-carnitin eller derivater deraf og antioxidanterInfo
- Publication number
- DK0797993T3 DK0797993T3 DK97103727T DK97103727T DK0797993T3 DK 0797993 T3 DK0797993 T3 DK 0797993T3 DK 97103727 T DK97103727 T DK 97103727T DK 97103727 T DK97103727 T DK 97103727T DK 0797993 T3 DK0797993 T3 DK 0797993T3
- Authority
- DK
- Denmark
- Prior art keywords
- antioxidants
- carnitine
- derivatives
- nervous system
- damage
- Prior art date
Links
- 239000003963 antioxidant agent Substances 0.000 title abstract 3
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title 1
- 208000032131 Diabetic Neuropathies Diseases 0.000 abstract 2
- 206010022562 Intermittent claudication Diseases 0.000 abstract 1
- 208000028389 Nerve injury Diseases 0.000 abstract 1
- 208000027089 Parkinsonian disease Diseases 0.000 abstract 1
- 206010034010 Parkinsonism Diseases 0.000 abstract 1
- 230000005856 abnormality Effects 0.000 abstract 1
- -1 alkanoyl L-carnitines Chemical class 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 210000000748 cardiovascular system Anatomy 0.000 abstract 1
- 210000003169 central nervous system Anatomy 0.000 abstract 1
- 206010008129 cerebral palsy Diseases 0.000 abstract 1
- 210000000987 immune system Anatomy 0.000 abstract 1
- 208000014674 injury Diseases 0.000 abstract 1
- 208000021156 intermittent vascular claudication Diseases 0.000 abstract 1
- 229930014626 natural product Natural products 0.000 abstract 1
- 230000008764 nerve damage Effects 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 210000001428 peripheral nervous system Anatomy 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 230000008733 trauma Effects 0.000 abstract 1
- 230000000472 traumatic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
- A61K38/063—Glutathione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Anti-Oxidant Or Stabilizer Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Fats And Perfumes (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT96RM000199A IT1283967B1 (it) | 1996-03-29 | 1996-03-29 | Uso di l-carnitina o derivati della l-carnitina ed antiossidanti nella prevenzione e trattamento di patologie derivanti da danni ossidativi |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0797993T3 true DK0797993T3 (da) | 2002-10-07 |
Family
ID=11404043
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK97103727T DK0797993T3 (da) | 1996-03-29 | 1997-03-06 | Præparater omfattende L-carnitin eller derivater deraf og antioxidanter |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US5998474A (es) |
| EP (1) | EP0797993B1 (es) |
| JP (1) | JPH1087483A (es) |
| KR (1) | KR100489371B1 (es) |
| AT (1) | ATE219360T1 (es) |
| CA (1) | CA2200540C (es) |
| DE (1) | DE69713431T2 (es) |
| DK (1) | DK0797993T3 (es) |
| ES (1) | ES2177843T3 (es) |
| IT (1) | IT1283967B1 (es) |
| PT (1) | PT797993E (es) |
| ZA (1) | ZA972671B (es) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1284661B1 (it) * | 1996-06-06 | 1998-05-21 | Sigma Tau Ind Farmaceuti | Uso di alcanoil l-carnitine nel trattamento terapeutico di malattie infiammatorie croniche intestinali. |
| IT1294227B1 (it) * | 1997-08-01 | 1999-03-24 | Sigma Tau Ind Farmaceuti | Composizione farmaceutica contenente l-carnitina o una alcanoil l-carnitina e alcoli alifatici a lunga catena utile per la prevenzione |
| DE19806890A1 (de) * | 1998-02-19 | 1999-08-26 | Beiersdorf Ag | Kosmetische und dermatologische Wirkstoffkombinationen aus mindestens einer Substanz gewählt aus der Gruppe, bestehend aus Carnitin und den Acylcarnitinen, und mindestens einem Antioxidans sowie Zubereitungen mit einem Gehalt an solchen Wirkstoffkombinationen |
| DE19806946A1 (de) * | 1998-02-19 | 1999-09-09 | Beiersdorf Ag | Kosmetische oder dermatologische Wirkstoffkombinationen aus mindestens einer Substanz gewählt aus der Gruppe, bestehend aus Carnitin und den Acylcarnitinen, und mindestens einem Retinoid sowie Zubereitungen mit einem Gehalt an solchen Wirkstoffkombinationen |
| IT1302125B1 (it) * | 1998-08-03 | 2000-07-31 | Sigma Tau Healthscience Spa | Composizione ad attivita' antiossidante ed antiproliferativacomprendente una carnitina ed un carotenoide |
| IT1302307B1 (it) * | 1998-09-01 | 2000-09-05 | Sigma Tau Healthscience Spa | Composizione ad attivita' antiossidante ed atta a migliorarel'utilizzazione metabolica del glucosio, comprendente acetil |
| IT1302365B1 (it) * | 1998-10-09 | 2000-09-05 | Sigma Tau Healthscience Spa | Uso di carnitine e resveratrolo per produrre una composizione per laprevenzione o il trattamento terapeutico di alterazioni cerebrali |
| AU1295700A (en) * | 1998-11-26 | 2000-06-13 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Use of fumarate salt of l-carnitine or its alkanoyl derivatives in ischaemia |
| IT1306130B1 (it) * | 1999-04-16 | 2001-05-30 | Sigma Tau Healthscience Spa | Composizione comprendente una carnitina e glutatione, atta adaumentare l'assorbimento del glutatione sinergizzandone gli effetti. |
| US6476010B2 (en) * | 2000-03-10 | 2002-11-05 | Hill's Pet Nutrition | Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals |
| US20030099727A1 (en) * | 2001-05-04 | 2003-05-29 | Yuanjin Tao | Compositions and methods for reducing cytotoxicity and inhibiting angiogenesis |
| US6923960B2 (en) * | 2001-10-03 | 2005-08-02 | Vsl Pharmaceuticals Inc. | Antioxidant combination composition and use thereof |
| ITRM20010695A1 (it) * | 2001-11-26 | 2003-05-26 | Sigma Tau Ind Farmaceuti | Uso della propionil l-carnitina o di un suo sale farmacologicamente accettabile per la preparazione di un medicamento per il trattamento del |
| FR2842422B1 (fr) * | 2002-07-16 | 2006-06-30 | Univ Aix Marseille Ii | Compositions destinees au traitement des neuropathies peripheriques, preparation et utilisations |
| CA2531056A1 (en) * | 2002-10-11 | 2004-04-22 | Creagri, Inc. | Therapeutic combination of carnitine and antioxidant polyphenols |
| JP2005187454A (ja) * | 2003-12-05 | 2005-07-14 | Sankyo Co Ltd | ビタミンｅ含有ｌｄｌ低下剤及び／又は動脈硬化抑制剤組成物 |
| US20080305094A1 (en) | 2004-01-28 | 2008-12-11 | Nestec S.A. | Nutritional Composition for Improving Skin Condition and Preventing Skin Diseases |
| US20050232911A1 (en) * | 2004-04-19 | 2005-10-20 | Schreiber Brian D | Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid |
| US20070225355A1 (en) * | 2004-06-29 | 2007-09-27 | Elixirin Corporation | Dietary Compositions for Enhancing Metabolism and Reducing Reactive Oxygen Species |
| TW200735863A (en) * | 2006-01-13 | 2007-10-01 | Elixirin Corp | Dietary compositions for enhancing metabolism and reducing reactive oxygen species |
| US20080226696A1 (en) * | 2007-03-15 | 2008-09-18 | Ben Treadwell | Methods of improving learning abilities of aged companion animals |
| US20110015154A1 (en) * | 2009-07-20 | 2011-01-20 | Kellermann Gottfried H | Supporting acetylcholine function |
| US20110098265A1 (en) * | 2009-10-28 | 2011-04-28 | Neuroscience, Inc. | Methods for reducing cravings and impulses associated with addictive and compulsive behaviors |
| JP6249511B2 (ja) * | 2014-04-01 | 2017-12-20 | エイチアンドディー エス．アール．エル． | 酸化的バランスの変化によってもたらされるリスクの診断的判定のための方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR4465M (es) * | 1965-06-28 | 1966-09-26 | ||
| US5292538A (en) * | 1992-07-22 | 1994-03-08 | Metagenics, Inc. | Improved sustained energy and anabolic composition and method of making |
| US5397786A (en) * | 1993-01-08 | 1995-03-14 | Simone; Charles B. | Rehydration drink |
| DE4335454A1 (de) * | 1993-10-19 | 1995-04-20 | Schleicher Peter | Geriatrikum |
| IT1275434B (it) * | 1995-05-19 | 1997-08-07 | Farmila Farma Milano | Composizioni farmaceutiche e/o dietetiche ad attivita' antiossidante |
-
1996
- 1996-03-29 IT IT96RM000199A patent/IT1283967B1/it active IP Right Grant
-
1997
- 1997-03-06 AT AT97103727T patent/ATE219360T1/de active
- 1997-03-06 ES ES97103727T patent/ES2177843T3/es not_active Expired - Lifetime
- 1997-03-06 DK DK97103727T patent/DK0797993T3/da active
- 1997-03-06 EP EP97103727A patent/EP0797993B1/en not_active Expired - Lifetime
- 1997-03-06 PT PT97103727T patent/PT797993E/pt unknown
- 1997-03-06 DE DE69713431T patent/DE69713431T2/de not_active Expired - Lifetime
- 1997-03-18 US US08/819,262 patent/US5998474A/en not_active Expired - Lifetime
- 1997-03-20 CA CA2200540A patent/CA2200540C/en not_active Expired - Lifetime
- 1997-03-27 ZA ZA9702671A patent/ZA972671B/xx unknown
- 1997-03-28 JP JP9077376A patent/JPH1087483A/ja active Pending
- 1997-03-29 KR KR1019970011380A patent/KR100489371B1/ko not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP0797993A1 (en) | 1997-10-01 |
| CA2200540C (en) | 2011-06-14 |
| ATE219360T1 (de) | 2002-07-15 |
| US5998474A (en) | 1999-12-07 |
| ZA972671B (en) | 1998-01-14 |
| IT1283967B1 (it) | 1998-05-07 |
| DE69713431D1 (de) | 2002-07-25 |
| CA2200540A1 (en) | 1997-09-29 |
| DE69713431T2 (de) | 2003-02-13 |
| KR100489371B1 (ko) | 2005-08-23 |
| EP0797993B1 (en) | 2002-06-19 |
| ITRM960199A1 (it) | 1997-09-29 |
| ITRM960199A0 (es) | 1996-03-29 |
| KR970064603A (ko) | 1997-10-13 |
| MX9702280A (es) | 1997-09-30 |
| ES2177843T3 (es) | 2002-12-16 |
| JPH1087483A (ja) | 1998-04-07 |
| PT797993E (pt) | 2002-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0797993T3 (da) | Præparater omfattende L-carnitin eller derivater deraf og antioxidanter | |
| ZA9610769B (en) | Pharmaceutical composition comprising l-carnitine or an alkanoyl l-carnitine in combination with a polyunsaturated fatty acid | |
| CA2314326A1 (en) | Transdermal therapeutic device and method with capsaicin and capsaicin analogs | |
| EP0196769A3 (en) | A novel transdermal pharmaceutical absorption dosage unit | |
| RU96108586A (ru) | Способ приготовления премикса | |
| PT89157A (pt) | Processo para a preparacao de uma formulacao de libertacao controlada de carbidopa/levodopa | |
| GB2276086A (en) | Pharmaceutical products for curing tumorous diseases and process for preparing same | |
| DE69506642D1 (de) | Pharmazeutische Zubereitungen enthaltend mehrfach ungesättigte Fettsäuren zusammen mit antioxydativen Vitaminen und Provitaminen | |
| IL82823A (en) | Controlled release oral dosage formulation of a combination of carbidopa and levodopa in the treatment of parkinsonism | |
| CA2109098A1 (en) | Activity-dependent neurotrophic factor | |
| SG50339A1 (en) | Fatty acid derivatives | |
| ITTV930035A0 (it) | Struttura di telaio di supporto particolarmente per ruote in linea di pattini | |
| CA2259152A1 (en) | Adenovirus e4 proteins for inducing cell death | |
| MX9304185A (es) | Producto y composicion farmaceutica que lo contiene para el tratamiento de la mastitis y la mestritis bovina. | |
| TW282468B (es) | ||
| DE3476736D1 (en) | Use of an antihypoxidoticum with cerebral and peripheral effect | |
| IL117991A0 (en) | Treatment of actinic keratosis displastic nevi and other proliferative skin disorders with topical clotrimazole | |
| GR3015373T3 (en) | 2-Halogen-substituted N-indolyl sulfonic-acid amides, process for their preparation and their pharmaceutical use. | |
| EP0539516A4 (es) | ||
| MX9603241A (es) | Productos farmaceuticos para curar enfermedades tumorales y procedimiento para su preparacion. | |
| HK1013962A (en) | Pharmaceutical composition containing gamma-hydroxybutyric acid or its lactone in the treatment of drug dependence and nutritional disorders | |
| Caballe | Effect of SO sub (2) on the human body degradation of vitamin B sub (1). | |
| IT1260150B (it) | Processo per la purificazione di forme mutate monomeriche del fattore neuronotrofico ciliare umano | |
| WO2001034178A3 (en) | Methods and compositions for treatment of traumatic brain injury | |
| RU92000959A (ru) | Лечебный напиток |